Serum Copeptin Levels in Threatened Preterm Labor

Area of Science:

• Reproductive Endocrinology
• Maternal-Fetal Medicine
• Biomarker Discovery

Background:

• Preterm birth is a leading cause of neonatal morbidity and mortality.
• Early identification of pregnancies at risk for preterm birth is crucial for timely intervention.
• Copeptin, a marker of stress and vasopressin release, has been explored as a potential biomarker in pregnancy complications.

Purpose of the Study:

• To evaluate the diagnostic and predictive utility of maternal serum copeptin levels for preterm birth.
• To assess the association between copeptin levels and threatened preterm labor.
• To determine if copeptin levels can predict the timing of delivery in at-risk pregnancies.

Main Methods:

• A case-control study involving 97 women with threatened preterm labor and 35 healthy controls.
• Maternal serum copeptin levels were measured and compared between groups.
• Correlation analysis was performed between copeptin levels and the likelihood of threatened preterm labor, timing of delivery, and time interval to delivery.

Main Results:

• Maternal serum copeptin levels were significantly higher in women with threatened preterm labor compared to the control group (p=0.04).
• No significant difference in copeptin levels was observed between women who delivered preterm and those who delivered at term (p=0.22).
• Copeptin levels did not correlate with the risk status or the occurrence of preterm birth.

Conclusions:

• Elevated serum copeptin levels are associated with threatened preterm labor.
• Maternal serum copeptin is not a reliable predictor of preterm birth or its timing.
• Further research may be needed to explore other potential roles or biomarkers in predicting preterm birth.